McWirter comments PLI at 05:15 http://watch.bnn.ca/#clip916491load up while u can at these levels, will trade 1$+ soon enough.Do your dd and read latest nr on q1 where revenues jumped again... ...

I couldn't agree more, mtnbkr. The main risk facing PLI at this juncture is 'execution risk' and frankly that is relatively small. In the protein division, revenue capacity of PLI's two manufacturing plants ($150M - Laval for PPPS; $100M Isle of Mann for resin) amounts to $250M/year which easily supports an sp of $3/share! What people don't seem to understand is that the par ...

q1 up 3,3M$ compared to last yearthis is called exponential growth, do your dd.================================================ ProMetic Reports Highlights of Its 2012 Annual and Special Meeting of Shareholders and Its First Quarter 2013 Financials Results- Revenues of $4.4 million in Q1 2013, an increase of $3.3 million compared to Q1 2012 - Revenues expected to exceed $11.0 million by the e ...

Today’s announcement of extending the strategic collaboration with Sartorius Stedim Biotech (SSB) is another example of how ProMetic Life Sciences (PLI) is building value by using its collaborative model to minimise dilution for shareholders. PLI entered into collaboration with SSB in 2006 and subsequent technology transfer deals had already established SSB as the preferred supplier of fi ...

Hi all, I copy below the question I emailed to Fred and his reponse. Btw, the rev estimates in the response are annual. Glta Stockman6767 ----------------------------------------- Hi Again Fred, I am wondering if we have an estimate of what this orphan drug could eventually represent in revenue to PLI when (hopefully) it eventually come to market ... and if we have an expected time frame for wh ...